Barcelona-based Biorce has raised €3.5 million in a funding round to develop its AI model, Jarvis, aimed at improving clinical trials.
Jarvis will streamline data accessibility in clinical trials by offering real-time, cross-referenced data access for patients, physicians, and researchers.
Biorce aims to address challenges in clinical trials, such as inefficiencies and data fragmentation, through its multi-modality platform and AI model.
The investment will support Biorce in enhancing clinical trial efficiency and bringing new treatments to market.